Report
Louis-Clément AZAIS d'UHART
EUR 112.46 For Business Accounts Only

Medium term view - ABBOTT LABORATORIES : The falling moving average confirms our opinion.

The trend has been momentarily interrupted by a correction. It approaches the resistance at $43.6000, which also is the invalidation level. It should cause a fall and resume the bearish trend. The next target is at $35.7000. The invalidation level is below $43.6000.

Arguments :
- The...
Underlying
Abbott Laboratories

Provider
Day By Day
Day By Day

​​DayByDay is an independent research company providing global macro and single stock analysis, recommendation and allocation based purely on behavioural finance methods. Those include long term cycle analysis, sentiment analysis, and technical trigger. DayByDay serves all clients in need of practical and precise publications to make effective market decisions, on any time horizon, from a few hours to a few years.

Analysts
Louis-Clément AZAIS d'UHART

Other Reports on these Companies
Other Reports from Day By Day

ResearchPool Subscriptions

Get the most out of your insights

Get in touch